United States· US:63629-2483_cae03204-d3a5-4e90-a629-3c7de0f15102
CROMOLYN SODIUM
A cromoglicic acid product containing cromolyn sodium, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cromoglicic acid is registered in 4 of 19 countries.
Countries holding a registration under ATC R03BC01 (cromoglicic acid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Cromoglicic acid · ATC R03BC01
4 / 19 countries
- Belgiumprice
- Finlandprice
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CROMOLYN SODIUM
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- R03BC01
- ATC class
- Cromoglicic acid
- Defined daily dose
- 40 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11636292483112 POUCH in 1 CARTON (63629-2483-1) / 8 AMPULE in 1 POUCH / 5 mL in 1 AMPULE
Regulatory notes
Interactions
130 interactions on record for cromoglicic acid.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cromoglicic acid · interactions on record
130 records
- 5 moderate
- 125 info
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cromoglicic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAllercrom 2% eye dropsViatris UK Healthcare Ltd
- NetherlandsAllerg-Abak 20 mg/ml, oogdruppels, oplossingLaboratoires Théa
- FinlandBlacilOrion Corporation Orion Pharma
- GermanyAllergovalKoehler Pharma Gmbh
- FranceALAIRGIX RHINITE ALLERGIQUE CROMOGLICATE DE SODIUM 2 %, solution pour pulvérisation nasaleCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- NorwayAllergovalKöhler Pharma
- BelgiumAlleophta Unidosis 20 mg/mlOpella Healthcare Belgium
- SwedenAllgil 20 mg/ml Ögondroppar, lösningEvolan Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Allergo-Comod, Allergocrom
- Belgium · Allergo-Comod, Cromabak
- Bulgaria · Lecrolyn Sine
- Cyprus · Cromodal, Vividrin
- Czechia · Allergo-Comod, Allergocrom
- Germany · Allergoval, Cromo
- Denmark · Lecrolyn Sine, Lomudal
- Estonia · Lecrolyn, Lecrolyn Sine
- Spain · Gastrofrenal
- Finland · Lecrolyn, Lecrolyn Sine
- France · Alairgix Rhinite Allergique, Allergocomod
- United Kingdom (Northern Ireland) · Alleopti Allergy, Alleopti Hayfever
- Greece · Allergotin, Chromoprol
- Hungary · Lecrolyn, Taleum
- Ireland · Opticrom, Opticrom Allergy
- Iceland · Lecrolyn Sine, Lomudal
- Italy · Brunicrom, Lecrosine
- Lithuania · Lecrolyn, Lecrolyn Sine
- Luxembourg · Allergo-Comod, Cromabak
- Latvia · Lecrolyn Sine
- Malta · Allergo-Comod, Allergotin
- Netherlands · Allerg-Abak, Allergieneusspray Natriumcromoglicaat Etos
- Norway · Lecrolyn Sine, Lomudal
- Poland · Allergo-Comod, Allergocrom
- Portugal · Allergocrom, Cromabak
- Romania · Alergorom, Lecrolyn
- Sweden · Allgil, Lecrolyn
- Slovakia · Allergocrom, Lecrolyn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddf7f512-cb33-48d2-adcc-23db68fc9222 GET /v1/drugs/ddf7f512-cb33-48d2-adcc-23db68fc9222?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "Q2WXR1I0PK",
"rxcui": "3538",
"inchikey": "VLARUOGDXDTHEH-UHFFFAOYSA-L",
"display_name": "CROMOLYN SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"18892411-465f-4d8d-9550-7dafa6c6a0a3": {
"match": "brand_token",
"title": "CROMOLYN SODIUM SOLUTION/ DROPS [PREFERRED PHARMACEUTICALS INC.]",
"spl_version": "5",
"published_date": "2026-04-02"
}
},
"productid": "63629-2483_cae03204-d3a5-4e90-a629-3c7de0f15102",
"productndc": "63629-2483",
"dosage_form": "SOLUTION, CONCENTRATE",
"orange_book": {
"appl_no": "209264",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AA",
"strength": "100MG/5ML",
"product_no": "001",
"approval_date": "Oct 16, 2017"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CROMOLYN SODIUM",
"shortage_reason": "Cromolyn Sodium Concentrate",
"shortage_status": "current",
"proprietary_name": "CROMOLYN SODIUM",
"active_ingred_unit": "mg/5mL",
"application_number": "ANDA209264",
"marketing_category": "ANDA",
"nonproprietary_name": "CROMOLYN SODIUM",
"start_marketing_date": "20171016",
"active_numerator_strength": "100"
}See everything about cromoglicic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.